Emerging Company Profile: The UK's Antikor Biopharma is advancing antibody fragment-drug conjugates (FDCs) closer to the clinic with plans for its first human study in 2019 or 2020.

Covalent Display Technology (CDT) is a fully in vitro display library platform, around which Isogenica Ltd. was founded in December 2000 . Its founders believe that CDT's properties--which allow the rapid construction of very large, easily automated libraries of diverse collections of biological compounds--offer clear advantages over existing phage display methods.